跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 683 条关于
“ESAS”
全部
683
临床试验
523
药物
45
机构
68
资讯
47
去年
Luspatercept Demonstrates Significant Reduction in Transfusion Burden in Lower-Risk MDS Patients: COMMANDS Trial
3年前
GSK's Jesduvroq Receives FDA Approval for Anemia in Dialysis-Dependent CKD Patients
2年前
Akebia Prepares Vafseo Launch for Dialysis Patients, Seeks Expansion to Pre-Dialysis Market
去年
Early Palliative Care Integration Improves Outcomes in Hepatocellular Carcinoma Patients
去年
Pegmolesatide Shows Promise as Long-Acting Anemia Treatment in Phase II Trials for CKD Patients
去年
Imetelstat Shows Consistent Benefit in MDS Patients Regardless of Prior Therapy
去年
Low-Dose Deferasirox Shows Promise in Treating Anemia in Low-Risk MDS
去年
Luspatercept Demonstrates Superior Efficacy in Frontline Treatment of Lower-Risk MDS
去年
Key Research Advances in MDS Treatment and Risk Assessment: 2024's Most Impactful Studies
去年
ESA Treatment Shows Survival Benefit in Lower-Risk Myelodysplastic Syndromes
第 1 页,共 5 页
上一页
下一页